Approval · Notice of Compliance 36749 · 2026
CEQUA: Notice of Compliance 36749
Issued January 14, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36749
- Date
- January 14, 2026
- Company
- Sun Pharmaceutical Industries LimitedMumbai, Maharashtra, India
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEQUA | Not yet assigned | — |
Medicinal ingredients
- CYCLOSPORINE 0.09 PER